Ovestin (Estriol)

Ovestin is an estrogen medication that acts on the hormonal pathways involved in menopause and related conditions.

• Menopausal vasomotor symptoms: Reduces the frequency and severity of hot flashes.
• Vaginal atrophy: Improves vaginal lubrication and tissue health.
• Osteoporosis prevention: Contributes to bone density maintenance in post‑menopausal women.

• Estradiol binds to estrogen receptors (ERα and ERβ) in target tissues, initiating genomic and non‑genomic signaling that regulates transcription of genes involved in reproductive, skeletal, and cardiovascular systems. This receptor activation restores estrogen‑dependent physiological functions that decline during menopause.

Adverse reactions may vary in frequency and severity.

Common Side Effects

• Nausea: Mild to moderate stomach upset.
• Breast tenderness: Sensitivity or swelling of breast tissue.
• Headache: Transient head pain.
• Fluid retention: Mild swelling of ankles or hands.
• Mood changes: Irritability or mild depressive symptoms.
• Vaginal bleeding: Spotting or breakthrough bleeding.

Serious or Rare Side Effects

• Thromboembolic events: Deep vein thrombosis or pulmonary embolism.
• Stroke: Cerebrovascular accident, especially in high‑risk patients.
• Liver dysfunction: Elevated liver enzymes or cholestasis.
• Endometrial hyperplasia: Abnormal thickening of the uterine lining.
• Breast cancer: Potential increased risk with long‑term use.
• Allergic reaction: Rash, itching, or anaphylaxis.

When prescribing Ovestin, clinicians should consider several safety aspects.

• Contraindication: Do not use in women with known estrogen‑dependent tumors.
• Cardiovascular risk: Assess history of thromboembolism or stroke before initiating therapy.
• Liver function: Monitor hepatic enzymes in patients with liver disease.
• Bone health: Evaluate baseline bone mineral density when used for osteoporosis prevention.
• Breast screening: Encourage regular mammography during treatment.
• Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Estradiol may interact with a range of concomitant medications.

Major Interactions (Avoid)

• Warfarin: Increases anticoagulant effect, raising bleeding risk.
• CYP3A4 inhibitors: Such as ketoconazole, may raise estradiol plasma levels.
• Aromatase inhibitors: Counteract estrogenic activity, reducing therapeutic effect.

Moderate Interactions (Monitor Closely)

• Anticonvulsants: Phenytoin, carbamazepine may lower estradiol concentrations.
• Selective serotonin reuptake inhibitors (SSRIs): May alter hormone metabolism.
• Thyroid hormones: Levothyroxine absorption can be affected.